The Law Offices of Howard G. Smith Reminds Investors of June 25th Deadline in the Class Action Lawsuit Against ACETO Corporation (ACET) - Adicet Bio (NASDAQ:ACET)

Investors suffering losses on their ACETO investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected].

On April 18, 2018, ACETO issued a press release announcing that its financial guidance should no longer be relied upon, that the Company anticipates recording non-cash intangible asset impairment charges in the range of $230 million to $260 million, and that Edward Borkowski resigned as the Company's CFO.

On this news, ACETO's share price fell $4.74 per share, or 64%, to close at $2.66 per share on April 19, 2018, thereby injuring investors.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

BENSALEM, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors of the June 25, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased ACETO Corporation ("ACETO" or the "Company") (NASDAQ:ACET) securities between February 1, 2018 and April 18, 2018, inclusive (the "Class Period"). ACETO investors have until June 25, 2018 to file a lead plaintiff motion.

The Complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) due to undisclosed competitive and pricing pressures, ACETO was unlikely to meet the performance metrics the Company provided to its investors as financial guidance; (ii) accordingly, ACETO's financial guidance was overstated; and (iii) as a result of the foregoing, ACETO's financial statements and Defendants' statements about ACETO's business, operations, and prospects, were materially false and misleading at all relevant times.

On this news, ACETO's share price fell $4.74 per share, or 64%, to close at $2.66 per share on April 19, 2018, thereby injuring investors.

If you purchased shares of ACETO during the Class Period you may move the Court no later than June 25, 2018 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com

ACETAdicet Bio Inc

$7.04-0.28%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.